Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release (Revised) Jul 10 2024

· Issued by Zydus Lifesciences Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-revised-jul-10-2024

Zydus Lifesciences Limited has informed the Exchange regarding a revised press release dated July 10, 2024, titled "Zydus receives final approval from USFDA for Sacubitril and Valsartan Tablets".

View Attachment

6ix hasn’t read this filing yet.

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases